首页> 外文期刊>Molecular pharmaceutics >Targeting l1 cell adhesion molecule using lentivirus-mediated short hairpin RNA interference reverses aggressiveness of oral squamous cell carcinoma.
【24h】

Targeting l1 cell adhesion molecule using lentivirus-mediated short hairpin RNA interference reverses aggressiveness of oral squamous cell carcinoma.

机译:使用慢病毒介导的短发夹RNA干扰靶向11细胞粘附分子可逆转口腔鳞状细胞癌的侵袭性。

获取原文
获取原文并翻译 | 示例
           

摘要

The L1 cell adhesion molecule (L1CAM) has been implicated in tumor progression of many types of cancers, but its role in oral squamous cell carcinoma (OSCC) has not been investigated. In the present study, we demonstrated overexpression of L1CAM in OSCC cells, but not in normal keratinocytes, using both clinical specimens and cell lines. This overexpression demonstrated a strong correlation with less differentiation and a higher invasion potential of cancer cells, supporting the significance of L1CAM in human OSCC tumor progression. Targeting L1CAM gene expression in SCC4 cells overexpressing L1CAM using a lentivirus-mediated small hairpin RNA (shRNA) led to a significant reduction in cell proliferation in vitro via retardation of cell cycle at the G1 phase. In addition, shRNA knockdown of L1CAM strongly attenuated the migration and invasion of SCC4 cells, and this was also observed to parallel increased E-cadherin levels and decreased levels of vimentin, fibronectin, and Snail-family transcription factors, indicating that L1CAM expression was related to the epithelial-mesenchymal transition. Furthermore, while mice receiving orthotopically placed control SCC4 cells died within 40 days due to invasive tumor growth and regional lymph node metastasis, prolonged animal survival and complete suppression of tumor progression was observed in mice implanted with L1CAM-deficent SCC4 cells, further substantiating the fundamental importance of L1CAM in OSCC pathophysiology. Our findings suggested that L1CAM is a critical mediator of tumor progression in OSCC, and targeting L1CAM using lentivirus-mediated shRNA may be a useful molecular pharmaceutical approach for the treatment of advanced OSCC.
机译:L1细胞粘附分子(L1CAM)已与许多类型的癌症的肿瘤进展有关,但尚未研究其在口腔鳞状细胞癌(OSCC)中的作用。在本研究中,我们使用临床标本和细胞系证明了OSCC细胞中L1CAM的过表达,而正常角质形成细胞中没有过表达。这种过表达证明与癌细胞的较少分化和较高的侵袭能力密切相关,支持了L1CAM在人OSCC肿瘤进展中的重要性。使用慢病毒介导的小发夹RNA(shRNA),在过表达L1CAM的SCC4细胞中靶向L1CAM基因表达,可通过延缓G1期的细胞周期,显着降低体外细胞增殖。此外,L1CAM的shRNA敲除极大地减弱了SCC4细胞的迁移和侵袭,并且还观察到这与E-钙粘蛋白水平的升高和波形蛋白,纤连蛋白和Snail家族转录因子水平的降低平行,这表明L1CAM表达与上皮-间质转化。此外,尽管接受原位放置的对照SCC4细胞的小鼠在40天内由于侵袭性肿瘤生长和区域淋巴结转移而死亡,但在植入了L1CAM缺陷的SCC4细胞的小鼠中观察到动物存活时间延长和肿瘤进展的完全抑制,这进一步证实了基础L1CAM在OSCC病理生理中的重要性。我们的发现表明,L1CAM是OSCC中肿瘤进展的关键介质,使用慢病毒介导的shRNA靶向L1CAM可能是治疗晚期OSCC的有用分子药物方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号